Report Overview

Canadas Diabetes market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 5.3% during the forecast period.

Diabetes is a chronic condition that affects Canadians of all ages. If left uncontrolled, diabetes results in consistently high blood sugar levels, which can lead to serious complications such as cardiovascular disease, vision loss, kidney failure, nerve damage, and amputation. According to the University of British Columbia, 29% of Canadians are living with diabetes or prediabetes. Canada has a 3.4 million known diabetes population. Recent studies show that although one in three Canadians is living with diabetes or prediabetes, yet knowledge of risk and complications of the disease remains low. only 33% of Canadians are aware that stroke is a complication of diabetes, only 40% of Canadians identified heart disease as a complication of diabetes.



Market Drivers

The major factors attributing to the growth of the market are Growing Disposable Income, Increasing Geriatric Population, Technological Advancement, and Increasing Healthcare Spending. In Canada type 2 diabetes accounts for 90 to 95% of diabetes cases, and due to an aging population, the prevalence of type 2 diabetes is expected to increase rapidly over the next few years. High-quality care, including adequate monitoring, control of risk factors, and active self-management are needed for preventing costly and burdensome micro-and macrovascular complications in Canadian patients with type 2 diabetes.